Lifestyle Before Medication

A pharmacist's perspective on health and metabolic disease

Should we use PCSK9 inhibitors?

I’ve just been asked about PCSK9 inhibitors.  These “Pesky” medications, which include the agents Alirocumab and Evolocumab, lower LDL cholesterol by inactivating a protein in the liver called called proprotein … Continue reading

August 10, 2016 · 5 Comments